FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty
company for the U.S. licensed medical cannabis industry, this morning announced
that it has agreed to a restructured agreement (“RA”) with Cultivation
Technologies Inc. (“CTI”) due to CTI’s re-focused business strategy towards
extraction, manufacturing, and brand development. Per the agreement, CTI will
pay FinCanna approximately $3.9 million as repayment of CTI’s outstanding
secured loan. FinCanna will also receive payments equal to 3.44% of the
consolidated topline revenue of CTI in perpetuity. CTI recently entered into a
sale escrow agreement for $4 million for its 6-acre property in Coachella,
California which is expected to close in December 2018 or January 2019 with
anticipated net proceeds of approximately $3.9 million after transaction costs
will be paid to FinCanna. CTI has the option to increase its cash payment to
FinCanna before December 31, 2018. The payments in perpetuity of 3.44% would be
modified based on total cash payments. Additionally, FinCanna will continue to
earn 50% of the profits of CTI’s Interim Extraction and Manufacturing Facility
that is expected to stay in operation until June 2019. FinCanna will also
receive certain purchase warrants in CTI’s next equity financing and will hold
customary security over its overriding royalty.
“The new agreement is a very positive move forward for
FinCanna and allows CTI to finance and execute on its refocused business to
create long-term value for both parties. We are very bullish on CTI’s new
strategy and anticipate a much quicker path to royalty revenue to FinCanna
without any further financing obligations. Lastly, the expected cash proceeds
from CTI of $3.9 million will provide us with additional non-dilutive funds to
expand our royalty investment portfolio with a goal to leverage additional
verticals in the U.S licensed cannabis markets that are in need of financing
for rapid growth,” FinCanna Capital President and CEO Andriyko Herchak stated
in the news release.
To view the full press release, visit http://ibn.fm/DqEd6
About FinCanna Capital Corp.
FinCanna provides financing to top-tier companies in the
licensed medical cannabis industry in exchange for a royalty on revenues.
FinCanna, led by a team of finance and industry experts, is building its
diversified portfolio of royalty investments in scalable, best-in-class
projects and companies in U.S. legal states, with a focus on California. For
additional information visit www.FinCannaCapital.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment